ThePrintPod: Tax doctors on research grants b...

Even as President-elect Donald Trump has vowed to remove millions of illegal immigrants from America, he’s using a 1954 deportation drive called Operation Wetback as his model. That effort caused enormous human suffering, and largely failed in its objectives. As long as businesse ...  Show more

Elections should prioritise pressing issues that shape people’s daily lives – policies, governance, and real challenges on the ground. But, as was evident in the 2024 Maharashtra assembly polls, the focus often shifts to narrative building, disregarding the substantive concerns t ...  Show more

Georgia Gov. Brian Kemp (R) has signed three innovative PBM reform bills into law. HB 946 and SB 313 require the reporting of drugs paid 10 percent above and 10 percent below National Average Drug Acquisition Cost every four months, prohibit PBMs from tying a pharmacy’s drug reim ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

If you had a rare disease and the only drug that could help you suddenly shot up in price how would you feel? What if your health service or insurer decided it was too expensive and they wouldn’t fund it any more? This is the problem facing some patients in the Netherlands.In ord ...  Show more

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billi ...  Show more